

Is Tazarotene in shortage in 2026? Get the latest update on Tazarotene availability, pricing, and what to do if you can't find your prescription.
If you rely on Tazarotene for acne, psoriasis, or skin aging, you may have noticed it's gotten harder to find at your pharmacy. While Tazarotene isn't listed as a formal shortage by the FDA in 2026, many patients are reporting difficulty filling their prescriptions — especially for certain strengths and generic formulations.
Here's what's going on, what it means for you, and what you can do about it.
As of February 2026, Tazarotene is not on the FDA's official drug shortage list. However, that doesn't mean it's easy to find. The FDA only lists shortages when supply falls significantly below demand at a national level. Regional and pharmacy-level shortages — where specific stores, chains, or areas can't get the medication — often fly under the radar.
What patients are experiencing in 2026:
Several factors are contributing to the current situation:
Generic Tazarotene is produced by only a handful of pharmaceutical companies. When even one manufacturer has a production delay, the remaining supply gets stretched thin. This is a common issue with specialty dermatology medications that have smaller market volumes.
Raw material sourcing for Tazarotene's active ingredient involves complex chemical synthesis, often dependent on overseas suppliers. Global logistics disruptions, regulatory inspections, and quality control issues at manufacturing facilities can all slow production.
Many chain pharmacies use automated ordering systems that stock based on recent dispensing history. If a location hasn't filled many Tazarotene prescriptions recently, it may not keep the medication on the shelf — even when it's available from wholesalers.
For a deeper dive, read why Tazarotene is so hard to find in 2026.
Cost is a major factor in Tazarotene access. Here's what you can expect to pay:
With insurance, your copay will depend on your plan's formulary tier. Many plans cover generic Tazarotene but may require prior authorization or step therapy (trying a cheaper retinoid like Adapalene or Tretinoin first).
Discount cards from GoodRx, SingleCare, and other services can lower the cash price of generic Tazarotene to around $40–$80 at some pharmacies. For all your savings options, see our guide to saving money on Tazarotene.
A few developments in 2026 may help improve access:
Here are the most effective steps you can take today:
Go to medfinder.com and search for Tazarotene with your zip code. You'll see which nearby pharmacies have it available right now.
If cream is out of stock, the gel version might be available (and vice versa). Talk to your doctor about whether a formulation switch would work for you. See our post on checking pharmacy stock for Tazarotene.
Independent pharmacies often have access to different wholesalers and may be able to source Tazarotene when chains can't.
If you've been unable to find Tazarotene for an extended period, your doctor may recommend switching to another retinoid like Tretinoin, Adapalene, or Trifarotene. Read our guide to Tazarotene alternatives for a full comparison.
Once you find Tazarotene, start refilling 7–10 days early to build in a buffer. Let your pharmacy know you're a regular user so they can include it in their routine ordering.
The Tazarotene supply situation in 2026 is frustrating but manageable. While there's no formal FDA shortage, real-world availability is inconsistent. The best thing you can do is stay proactive: use Medfinder to track stock, explore all available formulations, and keep an open line of communication with your dermatologist.
If you're a healthcare provider looking for clinical guidance, see our provider-focused shortage update.
You shouldn't have to put your skin care on hold. With the right tools and a little persistence, you can find Tazarotene — or an effective alternative — and keep your treatment on track.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.